stockrow
Friday 6 November 2026
Export XRAY’s income statement to Excel — free account
DENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
9.39
0.70
−6.94%
Follow XRAY
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 6 |
| (36.43%) | (37.73%) | (32.97%) | (8.55%) | ||
| (10.70%) | (11.14%) | (9.69%) | (2.23%) | ||
ROIC |
(8.71%) | (10.37%) | (6.23%) | (1.09%) | |
Return on Tangible Assets |
(38.81%) | (41.98%) | (34.38%) | (7.53%) | |
Average Days of Receivables |
68.24 | 61.68 | 62.12 | 61.77 | |
Free Cash Flow per Share |
0.52 | 0.52 | 0.74 | 1.37 | |
Free Cash Flow |
104.00 | 104.00 | 147.00 | 272.00 | |
Capital Expenditures |
(131.00) | (164.00) | (172.00) | — | |
| Other line items | |||||
Cash ROIC |
2.83% | 2.96% | 4.10% | 7.70% | |
Accounts Receivable Turnover |
5.92 | 6.00 | 5.76 | 5.68 | |
Accounts Payable Turnover |
6.80 | 7.03 | 6.97 | 6.99 | |
Inventory Turnover |
3.05 | 2.96 | 2.74 | 2.54 | |
Average Days of Payables |
59.51 | 50.28 | 51.60 | 49.11 | |
Days of Inventory on Hand |
127.35 | 127.94 | 131.99 | 145.88 | |
Tax Rate |
0.23 | 0.10 | 0.58 | 0.34 | |
Research and Development Expense of Revenue |
4.08% | 4.29% | 4.56% | 4.78% | |
Selling, General and Administrative Expense of Revenue |
39.08% | 38.88% | 39.88% | 40.87% | |
Share Based Compensation of Revenue |
0.90% | 0.84% | 0.85% | 0.92% | |
Interest Coverage |
(4.80) | (5.59) | (3.41) | (0.59) | |
Operating CF/Net income |
(0.39) | (0.43) | (0.58) | (2.25) | |
Depreciation/Fixed assets |
1.02 | 1.02 | 0.85 | 0.00 | |
Capex/Depreciation |
(0.15) | (0.19) | (0.24) | — | |
Revenue per Share |
18.46 | 18.41 | 18.24 | 17.95 | |
Operating CF per Share |
1.18 | 1.34 | 1.60 | 1.37 | |
Capex per Share |
(0.66) | (0.82) | (0.86) | 0.00 | |
Capex to Sales |
0.04 | 0.04 | 0.05 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026